Medicare Enrolled

Dr. Georgina Polanco Castillo, MD

Endocrinology · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8340 BANDFORD WAY STE 1, Raleigh, NC 27615
9198453332
In practice since 2011 (14 years)
NPI: 1578844775 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Polanco Castillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polanco Castillo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Polanco Castillo

Dr. Georgina Polanco Castillo is an endocrinology specialist in Raleigh, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Polanco Castillo performed 467 Medicare services across 282 unique beneficiaries.

Between the years covered by Open Payments, Dr. Polanco Castillo received a total of $4,373 from 49 pharmaceutical and/or device companies across 216 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Polanco Castillo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 467 Medicare services $4,373 industry payments

Medicare Practice Summary

Medicare Utilization ↗
467
Medicare services
Bottom 45% in NC for endocrinology
282
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $76 $212
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
81 $25 $71
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
80 $129 $285
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
62 $10 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $91 $320
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
19 $76 $222
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
12 $48 $102
New patient office visit, complex (60-74 min) 12 $158 $405
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,373
Total received (2018-2024)
Avg $625/year across 7 years
Top 37% in NC for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
216
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,086 (93.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287 (6.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$493
2023
$824
2022
$705
2021
$1,201
2020
$704
2019
$232
2018
$214

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$76
Novo Nordisk Inc
$54
SANOFI-AVENTIS U.S. LLC
$41
Lilly USA, LLC
$41
ABBVIE INC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
BETA BIONICS, INC.
$25
Xeris Pharmaceuticals, Inc.
$24
Amphastar Pharmaceuticals, Inc.
$23
IBSA Pharma Inc.
$23
Medtronic, Inc.
$20
Astellas Pharma US Inc
$20
Dexcom, Inc.
$15
Almatica Pharma LLC
$14
Amgen Inc.
$14
Novartis Pharmaceuticals Corporation
$14
Acella Pharmaceuticals, LLC
$13
CeQur Corporation
$12
Top 3 companies account for 34.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$664
Lilly USA, LLC
$385
Tandem Diabetes Care, Inc.
$273
Radius Health, Inc.
$263
Amgen Inc.
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
AstraZeneca Pharmaceuticals LP
$173
AbbVie Inc.
$139
SANOFI-AVENTIS U.S. LLC
$131
Xeris Pharmaceuticals, Inc.
$126
Abbott Laboratories
$123
Dexcom, Inc.
$123
Zealand Pharma US, Inc.
$105
UCB, Inc.
$99
PFIZER INC.
$98
ABBVIE INC.
$73
Currax Pharmaceuticals LLC
$71
Merck Sharp & Dohme Corporation
$60
RECORDATI_RARE_DISEASES_INC.
$60
Corcept Therapeutics
$58
CeQur Corporation
$58
Amarin Pharma Inc.
$56
Alexion Pharmaceuticals, Inc.
$54
Antares Pharma, Inc.
$53
Medtronic, Inc.
$53
IBSA Pharma Inc.
$40
Tolmar, Inc.
$38
Nestle HealthCare Nutrition Inc.
$36
Acella Pharmaceuticals, LLC
$36
Esperion Therapeutics, Inc.
$32
Novartis Pharmaceuticals Corporation
$31
Horizon Therapeutics plc
$31
Ascendis Pharma Inc
$26
BETA BIONICS, INC.
$25
MannKind Corporation
$24
Amphastar Pharmaceuticals, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Astellas Pharma US Inc
$20
Mannkind Corporation
$20
TOLMAR Pharmaceuticals, Inc.
$19
GRT US Holding, Inc.
$19
Merck Sharp & Dohme LLC
$18
Regeneron Healthcare Solutions, Inc.
$17
Medtronic MiniMed, Inc.
$17
Eisai Inc.
$16
VIVUS LLC
$16
Almatica Pharma LLC
$14
Roche Diabetes Care, Inc.
$13
Amneal Pharmaceuticals LLC
$12
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Accu-Chek Guide Me · BAQSIMI · CONTRAVE · CREON · CeQur Simplicity · DEXCOM G6 CGM SYSTEM · Dayvigo · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVKEEZA · FARXIGA · FENSOLVI · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LUPRON DEPOT · MINIMED 780G · MOUNJARO · Minimed 670G System · NEXLETOL · NP Thyroid 60 · Ozempic · PROCLAIM · Qsymia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SKYTROFA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TERIPARATIDE · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Raleigh?
Compare endocrinologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
49
Per 100K population
4.3
County median income
$101,763
Nearest hospital
REX HOSPITAL
7.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Polanco Castillo is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Polanco Castillo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Polanco Castillo performed 180 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polanco Castillo receive payments from pharmaceutical companies?
Yes. Dr. Polanco Castillo received a total of $4,373 from 49 companies across 216 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polanco Castillo's costs compare to other endocrinologists in Raleigh?
Dr. Polanco Castillo's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polanco Castillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →